Meta-Analysis Assessment of GP210 and SP100 for the Diagnosis of Primary Biliary Cirrhosis

被引：26

作者：

Hu, Shi-Ling ^{[1
]}

Zhao, Feng-Rong ^{[2
]}

Hu, Qin ^{[1
]}

Chen, Wei-Xian ^{[1
]}

机构：

[1] Chongqing Med Univ, Hosp 2, Dept Lab Med, Chongqing, Peoples R China

[2] Youyang Peoples Hosp, Dept Gynecol & Obstet, Chongqing, Peoples R China

来源：

PLOS ONE | 2014年 / 9卷 / 07期

基金：

中国国家自然科学基金;

关键词：

NUCLEAR-PORE COMPLEX; ANTINUCLEAR ANTIBODIES; AUTOANTIBODIES; PROTEINS; GLYCOPROTEIN; PREVALENCE; ENVELOPE; TESTS; POLYPEPTIDE; GUIDELINES;

D O I：

10.1371/journal.pone.0101916

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Purpose: To conduct a systematic review of included studies assessing the association of GP210 and SP100 with the risk of primary biliary cirrhosis (PBC) using meta-analysis. Methods: Five databases, the Cochrane Library, MEDLINE, VIP, CNKI, WANFANG were used to detect the role of GP210 and SP100 in diagnosis of PBC. Approximately 13,000 participants from several countries were included in this analysis. Meta-DiSc statistical software was used for analysis. Results: 25 studies on GP210 and 21 studies on SP100 were included in the meta-analysis. The DOR, sensitivity, specificity of GP210 in diagnosis of PBC were 24.854 (11.957-51.660), 0.272 (0.257-0.288), 0.985 (0.982-0.988), respectively, and they were 9.133 (4.739-17.600), 0.231 (0.213-0.249), 0.977 (0.973-0.981) for SP100. Conclusion: Our meta-analysis indicated both GP210 and SP100 had high specificity but low sensitivity in diagnosis of PBC.

引用

页数：9

共 50 条

[1] Quantification of serum gp210 and sp100 antibodies in diagnosis of primary biliary cholangitis
Mitova, T.
Dimitrova, Y.
Manolov, V.
Vasilev, V.
Popovska, T.
Yunchova, V.
Gerganov, M.
Dimitrov, V.
Angelov, T.
CLINICA CHIMICA ACTA, 2024, 558 : 38 - 38
[2] GP210 AND/OR SP100 ANTIBODIES IN PRIMARY BILIARY CIRRHOSIS: PREDICTORS OF CIRRHOSIS/AUTOIMMUNE (AIH) OVERLAP SYNDROMES?
Taiwo, O.
Mathew, S.
Van Vlymen, J.
Correa, A.
Deacock, S. J.
Berry, P.
Cheent, K.
Lewis, H.
Ala, A.
GUT, 2015, 64 : A263 - A263
[3] GP210 AND/OR SP100 AUTOANTIBODIES IN PRIMARY BILIARY CIRRHOSIS: PREDICTORS OF CIRRHOSIS/AUTOIMMUNE (AIH) OVERLAP SYNDROME?
Taiwo, O.
Mathew, S.
Van Vlymen, J.
Deacock, S.
Ala, A.
JOURNAL OF HEPATOLOGY, 2016, 64 : S644 - S644
[4] The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis
Luettig, B
Boeker, KHW
Schoessler, W
Will, H
Loges, S
Schmidt, E
Worman, HJ
Gershwin, ME
Manns, MP
JOURNAL OF HEPATOLOGY, 1998, 28 (05) : 824 - 828
[5] INCIDENTAL DETECTION OF SP100 AND GP210 IN PATIENTS WITH NORMAL LIVER FUNCTION TESTS
Moghaddas, Fiona
Toh, Ban-Hock
INTERNAL MEDICINE JOURNAL, 2014, 44 : 18 - 19
[6] Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis
Bauer, Alicja
Habior, Andrzej
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2007, 21 (04) : 227 - 231
[7] Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis
Huang, Chunyang
Han, Weijia
Wang, Chuanmin
Liu, Yanmin
Chen, Yue
Duan, Zhongping
DISEASE MARKERS, 2019, 2019
[8] Comment on "Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis"
Cristoferi, Laura
Invernizzi, Pietro
DISEASE MARKERS, 2020, 2020
[9] IFN ENHANCE EXPRESSION OF SP100, AN AUTOANTIGEN IN PRIMARY BILIARY-CIRRHOSIS
GULDNER, HH
SZOSTECKI, C
GROTZINGER, T
WILL, H
JOURNAL OF IMMUNOLOGY, 1992, 149 (12): : 4067 - 4073
[10] Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis
Nakamura, M
Takii, Y
Ito, M
Komori, A
Shimoda, S
Yokoyama, T
Mori, T
Koyabu, M
Matsuyama, M
Daikoku, M
Kamihira, T
Abiru, S
Nagaoka, S
Yano, K
Ohata, K
Matsumoto, T
Migita, K
Yatsuhashi, H
Ishibashi, H
HEPATOLOGY, 2005, 42 (04) : 465A - 466A

← 1 2 3 4 5 →